Literature DB >> 19291113

Silver resistance in MRSA isolated from wound and nasal sources in humans and animals.

Jia V Loh1, Steven L Percival, Emma J Woods, Nicola J Williams, Christine A Cochrane.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) colonises skin, nasal passages and dermal wounds. Methods used to manage wounds infected and colonised with MRSA often include the use of topical antiseptics such as ionic silver and iodine. The objectives of this study were to determine the prevalence of silver-resistance (sil) genes in MRSA and methicillin-resistant coagulase-negative staphylococci (MR-CNS) isolated from wounds and nasal cavities of humans and animals, and also to determine the susceptibility of sil-positive and sil-negative MRSA isolates to a silver-containing Hydrofiber (SCH) wound dressing, on planktonic silE-positive and silE-negative MRSA. Polymerase chain reaction was used to determine the presence of three silver-resistance (sil) genes, silE, silP and silS in 33 MRSA and 8 methicillin-resistant staphylococci (MR-CNS). SilP and silS genes were absent in all isolates tested; however, two MRSA strains were found to contain the silE gene, together with one isolate of MR-CNS. Phenotypic resistance of the silE-positive strains and their susceptibility to the SCH dressing was evaluated using the zone of inhibition test on Mueller Hinton agar, and confocal laser microscopy using a live/dead fluorescent stain. Results confirmed that the SCH dressing was effective in killing all MRSA strains with and without the silE gene. First, this study showed that the prevalence of sil genes was low in the isolates investigated; and secondly, that the presence of a silver-resistance gene (silE) in MRSA and MR-CNS did not afford protection to the organism in the presence of a SCH wound dressing. The use of topical antiseptics in chronic wound care should be considered before the use of antibiotics that can result in their overuse and the risk of further resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19291113      PMCID: PMC7951392          DOI: 10.1111/j.1742-481X.2008.00563.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  13 in total

1.  BSAC standardized disc susceptibility testing method.

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

Review 2.  Bacterial resistance to silver in wound care.

Authors:  S L Percival; P G Bowler; D Russell
Journal:  J Hosp Infect       Date:  2005-05       Impact factor: 3.926

3.  Glycopeptide resistance in staphylococci.

Authors:  K Hiramatsu; H Hanaki
Journal:  Curr Opin Infect Dis       Date:  1998-12       Impact factor: 4.915

4.  Bacterial resistance to silver-based antibiotics.

Authors:  Alan Lansdown; Angela Williams
Journal:  Nurs Times       Date:  2007 Feb 27-Mar 5

5.  Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates.

Authors:  Birgit Strommenger; Corinna Kehrenberg; Christiane Kettlitz; Christa Cuny; Jutta Verspohl; Wolfgang Witte; Stefan Schwarz
Journal:  J Antimicrob Chemother       Date:  2005-12-30       Impact factor: 5.790

6.  Prevalence of silver resistance in bacteria isolated from diabetic foot ulcers and efficacy of silver-containing wound dressings.

Authors:  Steven L Percival; Emma Woods; Moses Nutekpor; Phil Bowler; Alan Radford; Christine Cochrane
Journal:  Ostomy Wound Manage       Date:  2008-03       Impact factor: 2.629

7.  Retrospective analysis of plasmid patterns in a study of burn unit outbreaks of infection due to Enterobacter cloacae.

Authors:  S M Markowitz; S M Smith; D S Williams
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

Review 8.  Bacterial silver resistance: molecular biology and uses and misuses of silver compounds.

Authors:  Simon Silver
Journal:  FEMS Microbiol Rev       Date:  2003-06       Impact factor: 16.408

9.  Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

Authors:  R N Jones; C H Ballow; D J Biedenbach; J A Deinhart; J J Schentag
Journal:  Diagn Microbiol Infect Dis       Date:  1998-07       Impact factor: 2.803

10.  Methicillin-resistant staphylococci in companion animals.

Authors:  Keith E Baptiste; Kerry Williams; Nicola J Willams; Andrew Wattret; Peter D Clegg; Susan Dawson; John E Corkill; Turlough O'Neill; C Anthony Hart
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

View more
  22 in total

1.  Antibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria.

Authors:  Purushottam V Gawande; Kai P Leung; Srinivasa Madhyastha
Journal:  Curr Microbiol       Date:  2014-01-21       Impact factor: 2.188

2.  Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings.

Authors:  Mary Cloud B Ammons; Loren S Ward; Garth A James
Journal:  Int Wound J       Date:  2011-04-01       Impact factor: 3.315

3.  Unprecedented Silver Resistance in Clinically Isolated Enterobacteriaceae: Major Implications for Burn and Wound Management.

Authors:  Phillip J Finley; Rhy Norton; Cindy Austin; Amber Mitchell; Sara Zank; Paul Durham
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

Review 4.  Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.

Authors:  Min-Ho Kim
Journal:  IEEE Trans Nanobioscience       Date:  2016-03-02       Impact factor: 2.935

5.  Human skin wounds: a major and snowballing threat to public health and the economy.

Authors:  Chandan K Sen; Gayle M Gordillo; Sashwati Roy; Robert Kirsner; Lynn Lambert; Thomas K Hunt; Finn Gottrup; Geoffrey C Gurtner; Michael T Longaker
Journal:  Wound Repair Regen       Date:  2009 Nov-Dec       Impact factor: 3.617

6.  Essential oils and metal ions as alternative antimicrobial agents: a focus on tea tree oil and silver.

Authors:  Wan-Li Low; Ken Kenward; Stephen T Britland; Mohd Cim Amin; Claire Martin
Journal:  Int Wound J       Date:  2016-05-05       Impact factor: 3.315

7.  Repeated dose (28-day) administration of silver nanoparticles of varied size and coating does not significantly alter the indigenous murine gut microbiome.

Authors:  Laura A Wilding; Christine M Bassis; Kim Walacavage; Sara Hashway; Pascale R Leroueil; Masako Morishita; Andrew D Maynard; Martin A Philbert; Ingrid L Bergin
Journal:  Nanotoxicology       Date:  2015-11-02       Impact factor: 5.913

8.  Appropriate use of dressings containing nanocrystalline silver to support antimicrobial stewardship in wounds.

Authors:  Emma J Woodmansey; Christopher D Roberts
Journal:  Int Wound J       Date:  2018-08-17       Impact factor: 3.315

9.  Methylglyoxal-a potential risk factor of manuka honey in healing of diabetic ulcers.

Authors:  Juraj Majtan
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-14       Impact factor: 2.629

10.  Antibacterial efficacy testing of a bioelectric wound dressing against clinical wound pathogens.

Authors:  Hosan Kim; Inder Makin; Jeff Skiba; Amy Ho; Greggory Housler; Alexander Stojadinovic; Mina Izadjoo
Journal:  Open Microbiol J       Date:  2014-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.